The biopharmaceutical space has become increasingly competitive and it is now extremely tedious to scroll through hundreds of articles every day to track down all the latest scientific and technological breakthroughs on a specific disease or condition that interests you.
We are happy to announce that you can now prioritize diseases and conditions with Leo, your AI research assistant.
Let’s look at an example of how you could use Leo to prioritize disease. Imagine doing market and competitive intelligence in a pharmaceutical company and wanting to monitor clinical trials and regulatory updates on cardiovascular disease.
Cut the noise
You can train Leo to read your biopharmaceutical feeds and prioritize articles related to cardiovascular disease.
Leo continually reads the thousands of articles posted in your feeds. It’s an efficient way to cut the noise and keep up with the latest news on methodologies and clinical trials.
You are in control
We trained Leo to understand 5,000 diseases and conditions and 50,000 of their aliases from the MeSH database. This database belongs to the US National Library of Medicine and is used by major websites such as PubMed and ClinicalTrials.gov.
Asking Leo to prioritize cardiovascular disease in any of your biopharmaceutical feeds is as simple as creating a new topic priority and selecting “cardiovascular disease” as the topic.
When you make a “cardiovascular disease” priority, Leo will look for the aliases of cardiovascular disease but also for all disorders classified as cardiovascular disease in MeSH.
you can combine arguments with + AND and + OR and create even more focused priorities for Leo. For example, use + AND to focus on FDA approvals related to cardiovascular disease.
You can also ask Leo to look for a specific type of cardiovascular disease such as coronary heart disease.
Leo learns all the time
Leo is smart. Learn continuously from your feedback. When Leo is wrong, you can use the “Less like this” down arrow button to let him know that an article he prioritized is not about cardiovascular disease.
Find out how Feedly for Biopharma can help you and your team delve into the diseases and conditions you are researching.